Global Congress on Bladder Cancer 2018

Viewing 1-20 of 22 articles

Upper Tract Urothelial Carcinoma - Adjuvant Chemotherapy for all Patients?

Perioperative Chemotherapy in Cisplatin “Unfit” Patients

Controlling Symptoms in Metastatic Bladder Cancer

Saving Bladders with Brachytherapy Using Robot-Assisted Laparoscopically Performed Implantations for Solitary Muscle-Invasive Bladder Tumors

VISTA, Phase 3 Trial of Vicinium™, an EPCAM-Targeted Pseudomonas Exotoxin, in BCG – Unresponsive Non-Muscle Invasive Bladder Cancer

BCG vs Chemohyperthermia with Mitomycin C for High-Risk Non-Muscle Invasive Bladder Carcinoma: Preliminary Results of HIVEC-HR Randomized Clinical Trial

Bladder Cancer in the "Golden Years"

Chemohypertheramia with Mitomycin C and COMBAT System in High Risk Non-Muscle Invasive Bladder Cancer: A New Alternative?

How Can Diagnostic Imaging Influence the Treatment of Advanced Bladder Cancer?

Practical Considerations: What Every Clinician Should Know About Immune-Oncology

Atezolizumab as First-line Therapy in Patients with Cisplatin Ineligible Locally Advanced or Metastatic Urothelial Cancer: Efficacy by PD-L1 Status Over Time

Adjuvant Radiotherapy After Cystectomy: A Good Idea?

Variant Histology: What Pathology Can Tell You

Robotic Cystectomy: What is the Evidence?

Systemic Therapy in Advanced Urothelial Carcinoma: The Role of Chemotherapy

Immuno-oncology in Advanced Urothelial Carcinoma

Immuno Oncology in Advanced Bladder Cancer

Contemporary Advances in the Endoscopic Evaluation and Diagnosis of Bladder Cancer

What’s in the Boiling Pot of Non-Muscle Invasive Bladder Cancer

What You Need to Remember According to the Clinical Oncologist

1
2